Novoseven 2 Mg Injection

Name: Novoseven 2 Mg Injection
Brand: H K PHARMACEUTICALS
Price: 32500.0 INR
Availability: InStock

Price 32500.0 INR/ Piece

Get a Price/Quote

MOQ : 1 Piece

Novoseven 2 Mg Injection Specification

Packaging Type
1

Salt Composition
(Recombinant human coagulation Factor VIIa)

Pacakaging (Quantity Per Box)
1 vial

Origin of Medicine
india

Indication
Treatment and control of bleeding episodes in Hemophilia A with inhibitors Treatment and control of bleeding episodes in Hemophilia B with inhibitors Management of bleeding in Congenital Factor VII deficiency Treatment of bleeding in Acquired Hemophilia Control of bleeding episodes and use during surgical procedures in Glanzmann s Thrombasthenia (with platelet refractoriness

Drug Type
Injection

Ingredients
Hemophilia A or B with inhibitors Congenital Factor VII deficiency Acquired hemophilia Glanzmann s thrombasthenia (with platelet refractoriness

Physical Form
Other

Function
Other

Recommended For
Treatment and control of bleeding episodes in Hemophilia A with inhibitors Treatment and control of bleeding episodes in Hemophilia B with inhibitors Management of bleeding in Congenital Factor VII deficiency Treatment of bleeding in Acquired Hemophilia Control of bleeding episodes and during surgical procedures in Glanzmann s Thrombasthenia (with platelet refractoriness)

Dosage
90 micrograms/kg body weight Given by slow intravenous (IV) injection Can be repeated every 2 3 hours until bleeding is controlled

Dosage Guidelines
as per doctor prescription

Suitable For
Adults

Quantity
1 Unit

Storage Instructions
2 C to 8 C

Novoseven 2 Mg Injection Trade Information

Minimum Order Quantity
1 Piece

Delivery Time
2 Days

About Novoseven 2 Mg Injection

NovoSeven 2 mg contains Eptacog alfa (activated), a recombinant human coagulation Factor VIIa (rFVIIa). It is used for the treatment and control of bleeding episodes in patients with hemophilia and other rare bleeding disorders. The product is designed for rapid action to help initiate clot formation when normal clotting mechanisms are impaired.

Each pack includes a vial of sterile powder, a vial of solvent, and a vial adapter for reconstitution. NovoSeven is intended for single-dose intravenous administration after reconstitution.

Comprehensive Bleeding Control

Novoseven 2 mg Injection is engineered to effectively control and manage bleeding episodes in challenging cases such as Hemophilia A and B with inhibitors, rare coagulation disorders, and severe platelet dysfunction. Its targeted action offers a critical solution for patients where standard therapies may be insufficient, particularly during medical emergencies or surgical interventions.

Precise Dosing and Administration

The administration of Novoseven 2 mg Injection is strictly intravenous and dosage is determined by the physician, with a recommended 90 micrograms per kg body weight. The injections can be repeated every 2-3 hours as required until bleeding is controlled. Adhering to healthcare guidelines ensures both safety and therapeutic efficacy.

Proper Storage for Maximum Potency

To preserve its clinical effectiveness, Novoseven 2 mg Injection should be stored at a temperature range of 2C to 8C. It must remain in its original packaging until usage and avoid exposure to light, heat, or freezing temperatures. This ensures the integrity of the recombinant factor VIIa throughout its shelf life.

FAQ's of Novoseven 2 Mg Injection:

Q: How should Novoseven 2 mg Injection be administered?

A: Novoseven 2 mg Injection should be administered by slow intravenous (IV) injection by a qualified healthcare professional, following the prescribed dosage of 90 micrograms/kg of body weight. Repeat dosing may be required every 2-3 hours until bleeding is controlled, as directed by your physician.

Q: What are the specific indications for using Novoseven 2 mg Injection?

A: This injection is recommended for adults requiring treatment and control of bleeding episodes in Hemophilia A or B with inhibitors, Congenital Factor VII deficiency, Acquired hemophilia, and Glanzmann's thrombasthenia (with platelet refractoriness), including during surgical procedures.

Q: When should Novoseven 2 mg Injection be used?

A: Novoseven 2 mg Injection is typically used when there is active bleeding that cannot be managed with conventional therapies, or during surgeries in patients with specific coagulation disorders, as assessed by your doctor.

Q: Where should Novoseven 2 mg Injection be stored?

A: It should be kept refrigerated at a temperature between 2C and 8C. The vial should remain in the original packaging until ready for use and should not be frozen or exposed to extreme heat or light.

Q: What are the benefits of using Novoseven 2 mg Injection in bleeding disorders?

A: Novoseven provides prompt, targeted coagulation support for individuals who do not respond to standard treatments, rapidly controlling bleeding and reducing complications associated with serious coagulation disorders.

Q: How is the correct dosage for Novoseven determined?

A: The exact dosage is calculated based on body weight and the severity of bleeding, and should always follow your doctor's prescription and guidance.

Tell us about your requirement